Versarien Share Discussion Threads

[club sandwich] 21/2/2018 09:31

Woody - agreed. It just goes to show the sheer number of things happening in the background. Like China, this came out of a clear blue sky, no hints at all.

And there we all were thinking Pirelli would be next. Or Tesla... ;-)

[woodpeckers] 21/2/2018 09:30

I think one of the great things about this news is that it proves that though there are many on here who spend hours trying to track what Neill is up to, we still really have no clue just how many different avenues this company is going down.

That is why the market has difficulty putting any sort of value on it and probably always will. The possibilities are limitless and the following revenue incalculable.

[ashehzi] 21/2/2018 09:29

"Ellissj21 Feb '18 - 09:00 - 3464 of 3465" good point. Couple of my friends who were working in Diesel engine efficiency research @Ford few years ago moved to Electric as all money dried up in those Diesel projects and now rushing to all electric.

[adejuk] 21/2/2018 09:19

still a heavy seller. has to run dry soon.

[johnveals] 21/2/2018 09:18

RNS Number : 4572F

[ch1rp] 21/2/2018 09:16

Agree, Cielos. News after news of serious collaborations. They're not giving their technology away cheap. Multiple uses for nanene, 2D printing. Proper patents, farm out business models. Potential oozing out of this share and massive profits just round the corner.What's going on here?Who is going to get in cheap?????

[ayl30] 21/2/2018 09:14

Stig, yes after all we wouldn't want people to think it was going to be profitable would we ? (Irony)

[the stigologist] 21/2/2018 09:05

Just noticed it was a NON-RNS i.e. just a marketing press release not a proper regulatory one

Well done to Neill for ignoring/circumventing NOMAD and keeping shareholders informed even on 'non-significant'/'price sensitive' news

Shame on anyone who talks it up as being significant or price-sensitive

[compoundup] 21/2/2018 09:03

Pcj - that's right. Heard Neill say it.

[correction] - it was said in relation to exclusivity and licencing not straightforward "collaboration"

[ellissj] 21/2/2018 09:00

I was pleased to see neill give a nod to USA interest recently on twitter. And then he is pitching to europe in germany in march. Just thinking of the european car industry ; they bet wrong on diesel, gifting asia a head start on electric. Can they afford to be behind the nanene curve also ? Likewise tesla. Big money invested there. Could be all space junk ;) All to play for here. Aimo. Glalth. Best ellis

[pcjoe] 21/2/2018 08:59

Did the boss not say that the Co. would not enter into serious collaboration without upfront fee? - If I recall right a figure of £100k plus was mentioned

[ellissj] 21/2/2018 08:54

Indeed superg, with demand like that, its easy to imagine firms paying a fee to queue jump and then again to enter into collabs. Aimo. Best ellis

[superg1] 21/2/2018 08:52

MJ10

re

most collaborations excluding china will need set up costs extra staff


Not in the case of VRS there are not into funding wild R and D games by others.

EG they gave me an example some time back. My guess is small collaboration, they have others in play, we only get to see the bigger ones.

Company unknown wanted to collaborate and VRS pay half. VRS said no they are not into funding 3rd party collaborations etc they supply the product and expertise. That's the way they work.

With over 100 talking to them, I think near 200 now, then they have no need or time to mess around with those trying to get extra. It's a wheat from the chaff strategy at the moment. So there will be no lapdog type approach just because it's a big name.

They have plenty of big names in multiple sectors to talk too and many in the same sector. So the leverage in many cases is in the favour or VRS.

If you look at the tyre company answer there are 2 or 3 in talks, one advanced. If one cracks on then do the others close their eyes and face losing market share?

It's great place to be in. No bluffing or BS needed.

[eel tamer] 21/2/2018 08:49

They also have new revenue from the collaborations announced recently. No one is getting free Nanene.

[eel tamer] 21/2/2018 08:48

They raised double what they needed in last fundraiser so they have plenty of cash in the bank.

[diversification] 21/2/2018 08:46

I wonder if NR will be interviewed by JW today. Would be good to hear from him

[club sandwich] 21/2/2018 08:46

As far as I'm concerned VRS can do all the fundraisings they need to grow the company and achieve its potential. As NR has said many times, he's the biggest shareholder and he doesn't want to (unnecessarily) dilute his own stake: ergo if they raise funds it's for a very very good reason. I'd rather have a slightly smaller slice of a bigger pie...

[spike_1] 21/2/2018 08:45

IMO this collaboration in itself will not be significantly financially accretive for a long time (medical trials etc) BUT what it does do is: prove that Nanene can be medically safe!, and that ink applications should work, and more importantly perhaps, also work robustly on flexible 'fabrics', and fabrics are also all about elite (and other) sport, where cutting edge technologies appear quickly, and then rub off onto other stuff.

Best wishes - Mike

[dolores123] 21/2/2018 08:40

Many thanks Spike.

[alfie4048] 21/2/2018 08:38

Already up. See 7am ish

[spike_1] 21/2/2018 08:38

Medical Technology Collaboration



Versarien plc (AIM: VRS), the advanced materials engineering group, is pleased to announce that it has signed an agreement to develop a range of graphene based sensor technologies to enable the creation of digital bandages and wound dressings capable of various forms of physiological movement and excretion detection.

This project will utilise strain sensors printed with graphene ink using methods which have been developed by the Company's subsidiary, Cambridge Graphene Limited. Trials will take place at the internationally renowned Addenbrooke's Hospital in Cambridge with Orthopaedic surgeon Dr Arman Memanzedah leading the clinical trials. He will be joined by Dr Simon Rudland from Stowhealth who will be working with the team to optimise the usability of the data from the graphene dressings to ensure the optimal recovery of the patients post discharge. The agreement will also involve Dr Chris Crockford, Managing Director of Digital and Future Technologies Limited, who will act as liaison between the hospital, Versarien and wider global providers in this field

[dolores123] 21/2/2018 08:36

Could someone please put a copy of the RNS on this thread as I can't get it on my phone. Cheers

[mj10] 21/2/2018 08:32

eel
so you don't tink they will need extra staff then.the ceo will manage all the extra workload of running a multi million co on his own?

[fuji99] 21/2/2018 08:28

elliss - The few shorts have to close in an orderly manner in any case.
The only guilt that will be felt by a few will be: "Why did I sell at the threshold of agreements announcements in series ?". This can hunt one's life forever.

[tini5] 21/2/2018 08:21

We get touchy because those that mention the possibility of a fundraise clearly haven't done their research.